Evidence map›Paper›PMID 36768144›Full record

ArticleInternational journal of molecular sciences2023

A Newly Developed Chemically Defined Serum-Free Medium Suitable for Human Primary Keratinocyte Culture and Tissue Engineering Applications.

Sergio Cortez Ghio, Martin A Barbier, Emilie J Doucet, Imad Debbah, Meryem Safoine, Gaëtan Le-Bel, Andréanne Cartier, Emilie Jolibois, Amélie Morissette, Danielle Larouche and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. [Research advances on the application of skin appendage organoids in wound repair].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Nail Lacquer ContainingAntibiotics (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Sergio Cortez GhioThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Martin A BarbierThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Emilie J DoucetThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Imad DebbahThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Meryem SafoineThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Gaëtan Le-BelThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Andréanne CartierThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Emilie JoliboisThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Amélie MorissetteThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Danielle LaroucheThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Julie FradetteThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.
Sylvain L GuérinThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.ORCID 0000-0002-6767-5833
Alain GarnierDepartment of Chemical Engineering, Faculty of Sciences and Engineering, Université Laval, Quebec, QC G1V 0A6, Canada.
Lucie GermainThe Tissue Engineering Laboratory (LOEX), a Université Laval's Research Center, QC G1V 0A6, Canada.ORCID 0000-0001-8883-6491

Funding

Canadian Institutes of Health Research FDN-143213Canadian Institutes of Health Research IC-132948Fondation du CHU du Québec - Université Laval naFonds de Recherche du Québec en Santé naJoseph Demers scholarship naNational Science and Engineering Research Council of Canada naPierre J. Durand scholarship naQuebec Cell, Tissue and Gene Therapy Network naThe Fondation des Pompiers du Québec pour les Grands Brûlés na
6 · The paper itself

Abstract

In our experience, keratinocytes cultured in feeder-free conditions and in commercially available defined and serum-free media cannot be as efficiently massively expanded as their counterparts grown in conventional bovine serum-containing medium, nor can they properly form a stratified epidermis in a skin substitute model. We thus tested a new chemically defined serum-free medium, which we developed for massive human primary keratinocyte expansion and skin substitute production. Our medium, named Surge Serum-Free Medium (Surge SFM), was developed to be used alongside a feeder layer. It supports the growth of keratinocytes freshly isolated from a skin biopsy and cryopreserved primary keratinocytes in cultured monolayers over multiple passages. We also show that keratin-19-positive epithelial stem cells are retained through serial passaging in Surge SFM cultures. Transcriptomic analyses suggest that gene expression is similar between keratinocytes cultured with either Surge SFM or the conventional serum-containing medium. Additionally, Surge SFM can be used to produce bilayered self-assembled skin substitutes histologically similar to those produced using serum-containing medium. Furthermore, these substitutes were grafted onto athymic mice and persisted for up to six months. In conclusion, our new chemically defined serum-free keratinocyte culture medium shows great promise for basic research and clinical applications.

Indexed as

KeratinocytesTissue EngineeringAnimalsCells, CulturedCulture Media, Serum-FreeEpidermal CellsEpidermisHumansMiceSkinCulture Media, Serum-Freecell culturedefined mediumskinstem cellstissue engineering

Identifiers

PMID36768144
PMCPMC9915451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.